• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不可切除的肾母细胞瘤的管理

Management of unresectable Wilms tumor.

作者信息

Broecker B H, Perlmutter A D

出版信息

Urology. 1984 Aug;24(2):170-4. doi: 10.1016/0090-4295(84)90421-7.

DOI:10.1016/0090-4295(84)90421-7
PMID:6087534
Abstract

Wilms tumor has become a model of highly curable cancer. With the addition and refinement of chemotherapy protocols, survival rates have risen from 20 per cent three decades ago to 80 per cent or greater in the past decade. Surgery remains an integral part of the management of Wilms tumor both as a diagnostic tool and for removal of tumor bulk. Few primary tumors cannot be surgically removed during the initial phase of therapy. However, bilateral Wilms tumor and large unilateral tumors may occasionally be initially unresectable without prohibitive loss of renal or nonrenal organ function. The National Wilms Tumor Study group has no protocol for management of these tumors but does offer guidelines unsupported by large numbers of patients. Two cases are presented in which the tumors were initially deemed surgically unresectable. Initial management with chemotherapy (both cases) and radiotherapy (1 case) followed by surgical removal of tumor left both patients free of gross tumor, with relapse-free survivals of two and one-half years and six years thus far. Based on our experience and that found in the literature, we believe that preoperative chemotherapy is indicated for children suspected of having Wilms tumors judged surgically unresectable.

摘要

肾母细胞瘤已成为高度可治愈癌症的一个典范。随着化疗方案的增加和完善,生存率已从三十年前的20%上升到过去十年的80%或更高。手术仍然是肾母细胞瘤治疗不可或缺的一部分,既是一种诊断工具,也是用于切除大部分肿瘤。在治疗初始阶段,很少有原发性肿瘤不能通过手术切除。然而,双侧肾母细胞瘤和大型单侧肿瘤偶尔在初始阶段可能无法切除,除非肾脏或非肾脏器官功能有严重损失。国家肾母细胞瘤研究组没有针对这些肿瘤的治疗方案,但确实提供了一些没有大量患者数据支持的指导原则。本文介绍了两例肿瘤最初被认为无法手术切除的病例。最初采用化疗(两例均如此)和放疗(1例),随后手术切除肿瘤,两名患者均无肉眼可见肿瘤,迄今为止无瘤生存率分别为两年半和六年。基于我们的经验以及文献中的发现,我们认为对于怀疑患有经判断无法手术切除的肾母细胞瘤的儿童,术前化疗是必要的。

相似文献

1
Management of unresectable Wilms tumor.不可切除的肾母细胞瘤的管理
Urology. 1984 Aug;24(2):170-4. doi: 10.1016/0090-4295(84)90421-7.
2
Clinical outcomes of children with Wilms tumor treated on a SIOP WT 2001 protocol in a tertiary care hospital in south India.印度南部一家三级护理医院中按照 SIOP WT 2001 方案治疗的 Wilms 瘤患儿的临床结局。
J Pediatr Urol. 2018 Dec;14(6):547.e1-547.e7. doi: 10.1016/j.jpurol.2018.05.020. Epub 2018 Jun 28.
3
Preoperative chemotherapy for Wilms tumor.肾母细胞瘤的术前化疗。
Urology. 1982 Jan;19(1):55-60. doi: 10.1016/0090-4295(82)90047-4.
4
[Combined preoperative radio- and chemotherapy of nephroblastoma (Wilms' tumor)].肾母细胞瘤(威尔姆斯瘤)的术前放疗与化疗联合应用
Strahlentherapie. 1974 Feb;147(2):117-28.
5
Synchronous bilateral Wilm's tumor with complete radiographic response managed without surgical resection: a report from the National Wilm's Tumor Study 4.无需手术切除即可实现影像学完全缓解的同步双侧肾母细胞瘤:来自国家肾母细胞瘤研究4的报告
J Pediatr Surg. 2008 Nov;43(11):1982-4. doi: 10.1016/j.jpedsurg.2008.05.037.
6
Wilms' tumor: preoperative radiotherapy and chemotherapy in the management of massive tumors.肾母细胞瘤:巨大肿瘤治疗中的术前放疗和化疗
Cancer. 1970 Aug;26(2):338-40. doi: 10.1002/1097-0142(197008)26:2<338::aid-cncr2820260215>3.0.co;2-z.
7
Preoperative chemotherapy for children with Wilms' tumor.肾母细胞瘤患儿的术前化疗。
J Pediatr Surg. 1991 Aug;26(8):949-53; discussion 953-6. doi: 10.1016/0022-3468(91)90842-h.
8
Adult Wilms' tumor: management considerations.成人肾母细胞瘤:管理考量
Int Urol Nephrol. 2005;37(1):17-20. doi: 10.1007/s11255-004-4696-2.
9
[Risk factors for perioperative complications in renal surgery for Wilms' tumor].[肾母细胞瘤肾手术围手术期并发症的危险因素]
Aktuelle Urol. 2007 Jan;38(1):46-51. doi: 10.1055/s-2006-932158.
10
The management of Wilms' tumor: a comparison of two regimens.肾母细胞瘤的治疗:两种治疗方案的比较。
Cancer. 1974 Dec;34(6):2122-7. doi: 10.1002/1097-0142(197412)34:6<2122::aid-cncr2820340637>3.0.co;2-6.